SUJVIKA Portal and India’s Bioeconomy Push

Marking the 40th Foundation Day of the [“Department of Biotechnology”,”india government department”] (DBT), Union Minister Dr Jitendra Singh launched “SUJVIKA,” an AI-driven biotech product data portal developed in collaboration with industry body [“Association of Biotechnology Led Enterprises”,”india industry association”] (ABLE). The initiative reflects India’s ambition to build a 1 trillion bioeconomy by 2047 under the broader Viksit Bharat vision.</p> <h4>What Is SUJVIKA and Why It Matters?</h4> <p>SUJVIKA is a Trade Statistics Digital Intelligence Platform that provides authenticated data on biotechnology product imports. It offers sector-wise insights into:</p> <ul> <li>Biochemical products.</li> <li>Industrial enzymes.</li> <li>Other biotechnology imports.</li> </ul> <p>By presenting structured import data, the portal enables researchers, startups, and industry players to:</p> <ol> <li>Identify high-value and high-volume imports.</li> <li>Assess import dependency.</li> <li>Prioritise indigenisation and R&D efforts.</li> <li>Promote public-private partnerships.</li> </ol> <p>In essence, SUJVIKA supports evidence-based planning for strengthening domestic biomanufacturing.</p> <h4>India’s Expanding Bioeconomy</h4> <p>Over the past decade, India’s biotechnology ecosystem has grown rapidly:</p> <ul> <li>Biotech startups increased from fewer than 100 in 2014 to over 11,000.</li> <li>The bioeconomy expanded from nearly USD 10 billion in 2014 to about USD 165.7 billion in 2024.</li> <li>India emerged as one of the world’s leading vaccine manufacturers.</li> </ul> <p>This growth has been supported by DBT, [“Biotechnology Industry Research Assistance Council”,”india biotechnology agency”] (BIRAC), and the [“Biotechnology Research and Innovation Council”,”india research council”] (BRIC), which collectively foster academia-industry collaboration and startup incubation.</p> <h4>Policy Framework: BioE₃ and RDI Initiative</h4> <p>The recently approved BioE₃ Policy — Biotechnology for Economy, Environment and Employment — aims to strengthen high-performance biomanufacturing.</p> <p>Key pillars include:</p> <ul> <li>Integrated biological and digital intelligence systems.</li> <li>Promotion of sustainable bioindustrial models.</li> <li>Support for scale-up and commercialisation.</li> </ul> <p>A ₹2,000 crore national call under the ₹1 lakh crore Research, Development and Innovation (RDI) initiative is expected to further boost enterprises ready for large-scale growth.</p> <p>Additionally, the National Biofoundry Network — comprising six specialised biofoundries and 21 advanced bio-enabler facilities — seeks to accelerate industrial translation.</p> <h4>Emerging Frontiers: Space Biotechnology and Genomics</h4> <p>India is entering new domains through collaboration between DBT and [“Indian Space Research Organisation”,”india space agency”] (ISRO), exploring space biotechnology and space medicine.</p> <p>The [“GenomeIndia Project”,”india genomics initiative”] has sequenced whole genomes of 10,000 individuals across 99 diverse populations, with data hosted at the Indian Biological Data Centre. This initiative strengthens personalised medicine and genomic research capabilities.</p> <p>Further, India’s first human gene therapy trial for Severe Hemophilia A demonstrated sustained Factor VIII production, reducing reliance on repeated infusions — a milestone in indigenous biomedical innovation.</p> <h4>Digital Integration and AI in Biotechnology</h4> <p>Biotechnology’s integration with artificial intelligence is expected to:</p> <ul> <li>Enhance gene sequencing precision.</li> <li>Accelerate drug discovery timelines.</li> <li>Improve diagnostic accuracy.</li> <li>Reduce research costs.</li> </ul> <p>The revamped DBT website, aligned with the Government of India’s Digital Brand Identity Manual framework, also signals a push toward standardised digital governance.</p> <h4>Strategic Significance for Viksit Bharat 2047</h4> <p>The biotechnology sector is being positioned as a central driver of India’s next industrial revolution. By aligning science, industry and policy, India aims to:</p> <ol> <li>Strengthen self-reliance in critical bio-products.</li> <li>Enhance export competitiveness.</li> <li>Promote sustainable development.</li> <li>Create high-skilled employment.</li> </ol> <p>SUJVIKA, in this context, serves as a strategic intelligence tool linking trade data with innovation priorities.</p> <h4>What to Note for Prelims?</h4> <ul> <li>SUJVIKA: AI-driven biotech product import data portal.</li> <li>Launched by DBT in collaboration with ABLE.</li> <li>Bioeconomy grew to USD 165.7 billion in 2024.</li> <li>GenomeIndia Project sequenced 10,000 individuals.</li> <li>BioE₃ Policy focuses on economy, environment and employment.</li> </ul> <h4>What to Note for Mains?</h4> <ul> <li>Discuss biotechnology as a driver of India’s future economic growth.</li> <li>Examine the role of digital intelligence in strengthening industrial policy.</li> <li>Analyse how genomic initiatives can transform personalised healthcare.</li> <li>Evaluate India’s strategy to achieve a1 trillion bioeconomy by 2047.